Jugular lymphatic sacs in the first trimester of pregnancy: The prevalence and the potential value in screening for chromosomal abnormalities

Journal of Perinatal Medicine

Volumn 36, Issue 6, 2008, Pages 518-522

  Van Heesch, Peter N ^a   Struijk, Pieter C ^a   Brandenburg, Helen ^a   Steegers, Eric A ^a   Wildschut, Hajo I ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chromosomal abnormalities; First trimester screening; Jugular lymphatic sacs; Nuchal translucency; Sonographic marker

Indexed keywords

ADULT; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; JUGULAR LYMPHATIC SAC; LYMPH VESSEL; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING;

ADOLESCENT; ADULT; DOWN SYNDROME; FEMALE; FETAL DISEASES; HUMANS; LYMPHATIC SYSTEM; MASS SCREENING; NECK; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 55749108375     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2008.088     Document Type: Article

References (18)

1. Bekker MN. From lymphatic development to nuchal translucency. PhD thesis. Amsterdam: Buiten and Schipperheijn; 2007.
2. Bekker MN, Haak MC, Rekoert-Hollander M, Twisk J, Van Vugt JM. Increased nuchal translucency and distended jugular lymphatic sacs on first-trimester ultrasound. Ultrasound Obstet Gynecol. 2005;25:239-45.
3. Bekker MN, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac. Obstet Gynecol. 2006;108:846-53.
4. Bekker MN, van den Akker NM, Bartelings MM, Arkesteijn JB, Fischer SG, Polman JA, et al. Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy. J Soc Gynecol Investig. 2006;13:209-16.
5. Gittenberger-De Groot AC, Van Den Akker NM, Bartelings MM, Webb S, Van Vugt JM, Haak MC. Abnormal lymphatic development in trisomy 16 mouse embryos precedes nuchal edema. Dev Dyn. 2004; 230:378-84.
6. Haak MC. Nuchal translucency and cardiac failure. PhD thesis. Wageningen: Ponsen and Looijen; 2003.
7. Haak MC, Bartelings MM, Jackson DG, Webb S, van Vugt JM, Gittenberger-de Groot AC. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod. 2002;17:1086-92.
8. Holtzman DM, Bayney RM, Li YW, Khosrovi H, Berger CN, Epstein CJ, et al. Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. Embo J. 1992;11:619-27.
9. Miyabara S, Gropp A, Winking H. Trisomy 16 in the mouse fetus associated with generalized edema and cardiovascular and urinary tract anomalies. Teratology. 1982;25:369-80.
10. Pandya PP, Santiago C, Snijders RJ, Nicolaides KH. First trimester fetal nuchal translucency. Curr Opin Obstet Gynecol. 1995;7:95-102.
11. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet. 1995;11:177-84.
12. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998;352:343-6.
13. Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation. Am J Med Genet. 1999;86:205-7.
14. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol. 1998;11:391-400.
15. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol. 2005;192:1005-21.
16. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol (Berl). 1998;197:105-24.
17. von Kaisenberg CS, Nicolaides KH, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum Reprod. 1999;14:823-6.
18. Zoppi MA, Ibba RM, Putzolu M, Floris M, Monni G. Assessment of risk for chromosomal abnormalities at 10-14 weeks of gestation by nuchal translucency and maternal age in 5,210 fetuses at a single centre. Fetal Diagn Ther. 2000;15:170-3.